Given that no therapeutic methods of postoperative adjuvant chemotherapy for non-small-cell lung cancer have been established, we selected UFT (tegafur and uracil) for investigation because UFT is less injurious to the host
Shigeki Hitomi, MD, PhD
Advertisement
Articles by Shigeki Hitomi, MD, PhD
Advertisement
Latest Updated Articles
- Postoperative Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer
Published: September 2nd 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
3
FDA Grants FTD to Novel Cancer Vaccine in Low Tumor Burden Follicular Lymphoma
4
Should Those with Non-Hodgkin Lymphoma Receive CAR T or Bispecifics?
5
